Ingefors Sofia, Adrian Maria, Heckley Gawain, Borgquist Ola, Kander Thomas
Medical Faculty, Lund University, Lund, Sweden.
Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
J Vasc Access. 2025 Mar;26(2):487-496. doi: 10.1177/11297298231222929. Epub 2024 Jan 24.
It is well-known that infectious complications after central venous catheterisation are associated with increased mortality, length of hospital stay and costs. However, there are limited data regarding such associations for immediate insertion-related complications. Therefore, the aim of this study was to investigate whether major immediate insertion-related complications are associated with mortality, length of hospital stay and costs.
This was a preplanned substudy to the CVC-MECH trial on immediate insertion-related complications after central venous catheterisation in the ultrasound-guided era. Patients receiving central venous catheters at Skåne University Hospital from 2 March 2019 to 31 December 2020 were prospectively included. Patient characteristics, clinical data and costs were automatically collected from medical journals and the patient administration system. Associations between major immediate insertion-related complications and mortality, length of hospital stay and costs were studied by multivariable logistic and linear regression analyses.
In total, 6671 patients were included, of whom 0.5% suffered major immediate insertion-related complications. Multivariable analyses, including surrogates for general morbidity, showed associations between major immediate insertion-related complications and 30-day (odds ratio 2.46 [95% CI 1.05-5.77]), 90-day (2.90 [1.35-6.21]) and 180-day (2.26 [1.05-4.83]) mortality. There were no associations between major immediate insertion-related complications and increased length of hospital stay or costs.
This study showed that major immediate insertion-related complications, although not directly responsible for any death, were associated with increased 30-day, 90-day and 180-day mortality. These findings clearly demonstrate the importance of using all possible means to prevent avoidable insertion-related complications after central venous catheterisation.
众所周知,中心静脉置管后的感染并发症与死亡率增加、住院时间延长及费用增加相关。然而,关于此类与置管即刻相关并发症的关联数据有限。因此,本研究的目的是调查主要的置管即刻相关并发症是否与死亡率、住院时间及费用相关。
这是一项针对超声引导时代中心静脉置管后即刻相关并发症的CVC-MECH试验的预先计划的子研究。前瞻性纳入了2019年3月2日至2020年12月31日在斯坎纳大学医院接受中心静脉导管置入的患者。患者特征、临床数据和费用从医学期刊和患者管理系统中自动收集。通过多变量逻辑回归和线性回归分析研究主要的置管即刻相关并发症与死亡率、住院时间及费用之间的关联。
总共纳入了6671例患者,其中0.5%发生了主要的置管即刻相关并发症。多变量分析,包括一般发病率的替代指标,显示主要的置管即刻相关并发症与30天(比值比2.46 [95%可信区间1.05 - 5.77])、90天(2.90 [1.35 - 6.21])和180天(2.26 [1.05 - 4.83])死亡率之间存在关联。主要的置管即刻相关并发症与住院时间延长或费用增加之间无关联。
本研究表明,主要的置管即刻相关并发症虽然并非直接导致任何死亡,但与30天、90天和180天死亡率增加相关。这些发现清楚地证明了采取一切可能手段预防中心静脉置管后可避免的置管相关并发症的重要性。